Financhill
Sell
39

PRAX Quote, Financials, Valuation and Earnings

Last price:
$38.13
Seasonality move :
-27.79%
Day range:
$36.63 - $38.97
52-week range:
$26.70 - $91.83
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
87.69x
P/B ratio:
1.77x
Volume:
660.5K
Avg. volume:
545K
1-year change:
-27.31%
Market cap:
$775.9M
Revenue:
$8.6M
EPS (TTM):
-$10.72

Earnings Data

Next earnings date for PRAX
Aug 13
2025
Most recent earnings per share
-$3.29
Missed by $0.08
(May 2/2025)
Consensus Estimate
-$3.21
(May 2/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PRAX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/13/2025 Q2 $198.8K -- -- -$3.31 --
05/02/2025 Q1 $183.1K -- -$3.29 -$3.21 -$0.08
03/05/2025 Q4 $362.3K $7.5M -$2.94 -$2.82 -$0.12
11/06/2024 Q3 $295.7K $302K -$2.75 -$1.95 -$0.80
08/13/2024 Q2 $833.1K $357K -$1.74 -$2.32 $0.58
05/10/2024 Q1 $1.6M $431K -$2.84 -$2.16 -$0.68
03/05/2024 Q4 $50K $515K -$1.96 -$3.17 $1.21
11/07/2023 Q3 -- $468K -$2.72 -$4.89 $2.17
08/09/2023 Q2 -- $781K -$7.38 -$10.60 $3.22
05/11/2023 Q1 -- $683K -$10.58 -$12.80 $2.22
02/07/2023 Q4 -- -- -$13.05 -- --
11/09/2022 Q3 -- -- -$14.40 -- --
08/08/2022 Q2 -- -- -$19.80 -- --
05/09/2022 Q1 -- -- -$22.65 -- --
02/28/2022 Q4 -- -- -$19.50 -- --
11/03/2021 Q3 -- -- -$15.00 -- --
08/16/2021 Q2 -- -- -$13.20 -- --
05/11/2021 Q1 -- -- -$10.65 -- --
03/17/2021 Q4 -- -- -$10.45 -- --
11/23/2020 Q3 -- -- -$8.23 -- --
06/30/2020 Q2 -- -- -$11.88 -- --
03/31/2020 Q1 -- -- -$8.65 -- --
12/31/2019 Q4 -- -- -$7.95 -- --
09/30/2019 Q3 -- -- -$10.37 -- --

Praxis Precision Medicines Earnings Questions

  • How Much did Praxis Precision Medicines Generate in Revenue Last Quarter?

    Praxis Precision Medicines reported -- worth of top line sales in its most recent quarter.

  • Did Praxis Precision Medicines Beat Earnings Last Quarter?

    Praxis Precision Medicines announced earnings per share of -$3.29 which represents a miss of analyst forecast a -$3.21 per share.

  • Is Praxis Precision Medicines Profitable?

    Praxis Precision Medicines reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Praxis Precision Medicines EPS Next Year?

    Praxis Precision Medicines's earnings are forecast to decrease from -$10.21 per share to -$10.10 per share next year representing a decrease of -29.34%.

  • When is Praxis Precision Medicines's Earnings Date?

    Praxis Precision Medicines's next earnings date is August 13, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

5 Investors to Follow Other Than Warren Buffett
5 Investors to Follow Other Than Warren Buffett

There is no doubt that Warren Buffett is one of…

Is BYD a Threat To Tesla Shareholders?
Is BYD a Threat To Tesla Shareholders?

BYD (OTC:BYDDY) has rocketed to the top of China’s booming…

CVX Vs XOM Stock, Which Energy Play Is Best?
CVX Vs XOM Stock, Which Energy Play Is Best?

Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
60
RGC alert for May 8

Regencell Bioscience Holdings [RGC] is up 10.54% over the past day.

Buy
92
TPB alert for May 8

Turning Point Brands [TPB] is down 6.67% over the past day.

Buy
74
LIVN alert for May 8

LivaNova PLC [LIVN] is up 1.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock